AI & RoboticsNews

Report: 40% of execs say increasing business process efficiency is top benefit of AI

According to a new report from CognitiveScale, 40% of respondents identified increasing business process efficiency as the top benefit to gain from deploying AI, while another 36% of respondents identified improving customer service as the top benefit. The adoption of artificial intelligence is growing worldwide. The need to boost customer service, employee efficiency, and acceleration of…
Read more
AI & RoboticsNews

Synthesis AI offers API for virtual humans

Join gaming leaders online at GamesBeat Summit Next this upcoming November 9-10. Learn more about what comes next.  Synthesis AI, a synthetic data company, has released HumanAPI, a new tool for generating virtual humans from synthetic data.  Virtual humans are…
AI & RoboticsNews

Nvidia unveils AI Omniverse Avatars for the virtual world

Join gaming leaders online at GamesBeat Summit Next this upcoming November 9-10. Learn more about what comes next.  Nvidia today unveiled Omniverse Avatar, a platform for generating immersive AI-driven avatars. The platform enables users to leverage speech AI, computer vision, natural language understanding, and simulation to create avatars that recognize speech and communicate with human users…
Read more
AI & RoboticsNews

Nvidia’s enterprise AI development LaunchPad program goes global

At its ongoing GTC conference, computing giant Nvidia has announced the expansion of its AI LaunchPad program, making it available at 10 locations around the world — Silicon Valley, Dallas, Washington, D.C., London, Paris, Amsterdam, Frankfurt, Paris, Singapore, and Tokyo. Initially restricted to Equinix datacenters in North America, LaunchPad gives enterprises immediate access to Nvidia-powered…
Read more
AI & RoboticsNews

AI Weekly: Corporate AI labs’ turn toward commercial research highlights need for investment in basic science

Google’s parent company Alphabet last week launched a subsidiary focused on AI-powered drug discovery called Isomorphic Labs. Helmed by Demis Hassabis, the cofounder of DeepMind, Isomorphic will use AI to identify disease treatments that have thus far eluded researchers, according to a blog post. “Isomorphic Labs [is] a commercial venture with the mission to reimagine the entire drug discovery…
Read more